These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 122781)

  • 1. [Hemodynamic effects of various doses of a new inotropic: amrinoma].
    Cárdenas M; Vidaurri A
    Arch Inst Cardiol Mex; 1979; 49(5):961-8. PubMed ID: 122781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA
    Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
    Veit S; Brückner JB; Vogt K; Wagner R; Hess W
    Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic assessment of amrinone. A new inotropic agent.
    Benotti JR; Grossman W; Braunwald E; Davolos DD; Alousi AA
    N Engl J Med; 1978 Dec; 299(25):1373-7. PubMed ID: 714115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
    Hashimoto K; Yabuuchi Y; Yamashita S; Mori T
    Arzneimittelforschung; 1984; 34(3A):390-3. PubMed ID: 6540094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
    Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV
    J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related cardiovascular effects of amrinone during enflurane anesthesia in the dog.
    Makela VH; Kapur PA
    Anesth Analg; 1986 Aug; 65(8):849-52. PubMed ID: 3729021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of the bipyridines: amrinone and milrinone.
    Alousi AA; Johnson DC
    Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure.
    Sonnenblick EH; Grose R; Strain J; Zelcer AA; LeJemtel TH
    Circulation; 1986 Mar; 73(3 Pt 2):III162-7. PubMed ID: 3510772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM; Pugh S; Noble MI
    Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of amrinone administered orally and by injection in heart failure].
    Bounhoure JP; Massabuau P; Puel J; Miquel JP; Calazel J
    Ann Med Interne (Paris); 1985; 136(3):251-5. PubMed ID: 3896092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amrinone: a promising new cardiotonic agent in the treatment of chronic cardiac failure.
    Likoff MJ; Weber KT; Andrews V; Janicki JS
    Herz; 1983 Aug; 8(4):199-205. PubMed ID: 6413341
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodynamic effects of amrinone in dogs anesthetized with halothane: comparison with isoproterenol and dobutamine.
    Boncyk J; Redon D; Rusy B
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):347-54. PubMed ID: 6463363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function.
    Wilmshurst PT; Thompson DS; Jenkins BS; Coltart DJ; Webb-Peploe MM
    Br Heart J; 1983 Jan; 49(1):77-82. PubMed ID: 6821613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle.
    Gaide MS; Kimura S; Lodge NJ; Cameron JS; Kozlovskis PL; Myerburg RJ; Bassett AL
    Circulation; 1986 Mar; 73(3 Pt 2):III36-45. PubMed ID: 3943180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation].
    Kabela E; Michaels DC; Felice EL
    Arch Inst Cardiol Mex; 1979; 49(5):892-907. PubMed ID: 398199
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced relaxation and reduced positive inotropic effects of amrinone in ventricular muscle from cats with subacute heart failure. Implications for drug therapy.
    Bassett AL; Gaide MS; Lodge NJ; Cameron JS
    Adv Myocardiol; 1985; 6():629-36. PubMed ID: 2986264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of amrinone, a new non-digitalic positive inotropic agent, on the efficiency and coronary circulation of the heart].
    Bárcenas L; Kabela E
    Arch Inst Cardiol Mex; 1984; 54(5):431-40. PubMed ID: 6517640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure].
    Dei Cas L; Metra M; Nodari S; Raddino R; Visioli O
    Cardiologia; 1991 May; 36(5):363-71. PubMed ID: 1756541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.